Randall Lutter Appointed FDA Acting Deputy For Policy
This article was originally published in The Pink Sheet Daily
Executive Summary
Lutter will step in when Scott Gottlieb leaves the post Jan. 16.
You may also be interested in...
Deputy Commissioner Scott Gottlieb To Leave FDA Jan. 16
Gottlieb will return to the American Enterprise Institute to work on health policy issues with former FDA/CMS chief Mark McClellan.
McClellan Resigns As Head Of CMS, Claiming Drug Benefit Is On A Stable Track
McClellan notes accomplishments in implementing Medicare Part D as he ends two-and-a-half years as Medicare and Medicaid chief.
Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.